N05.A
Unspecified nephritic syndrome with C3 glomerulonephritis
Clinical Classification Guidelines
Inclusion Terms
- Unspecified nephritic syndrome with C3 glomerulopathy
Excludes Type 1
- Unspecified nephritic syndrome (with C3 glomerulopathy) with dense deposit disease (N05.6)
Medical Intelligence & Overview
Unspecified nephritic syndrome with C3 glomerulonephritis is a kidney condition characterized by inflammation of the glomeruli—the tiny filtering units within the kidneys. This condition involves an abnormal immune response leading to damage in the kidney's filtering system, which can affect kidney function. It is classified under ICD-10 code N05.A and is a subtype of nephritic syndromes associated specifically with C3 glomerulopathy, a disorder involving the complement system, part of the immune response. Understanding this condition can help in recognizing its impact on health and potential management options.
Causes & Symptoms
Clinical Causes: Immune system dysfunction that leads to abnormal activation of the complement pathway, specifically affecting C3 proteins Genetic factors that predispose individuals to complement dysregulation Infections that may trigger or exacerbate immune responses affecting the kidneys Other autoimmune conditions that contribute to immune complex deposition in the glomeruli
Key Symptoms: Hematuria (presence of blood in the urine), often causing urine to appear cola-colored Proteinuria (excess protein in the urine), which can lead to swelling and puffiness High blood pressure (hypertension) Swelling in the legs, ankles, or around the eyes Reduced kidney function, which may lead to fatigue and malaise in advanced stages Dark-colored urine and foamy appearance due to protein Potential signs of kidney failure in severe cases, such as fluid retention and nausea
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and laboratory tests. These may include blood tests to assess kidney function and levels of complement proteins, urinalysis to detect blood and protein, and imaging studies like ultrasound. A kidney biopsy is often necessary to confirm the diagnosis, revealing characteristic changes in the glomeruli, including C3 deposits, which are indicative of C3 glomerulonephritis.
Treatment Protocols: While there is no specific cure for this condition, treatment focuses on managing symptoms and slowing disease progression. Strategies may include: - Medications such as corticosteroids or immunosuppressants to reduce inflammation and immune activity - Blood pressure control using antihypertensive drugs - Dietary adjustments to limit salt and protein intake, supporting kidney health - Regular monitoring of kidney function and urine analysis - In some cases, plasmapheresis or complement inhibitors might be considered to address immune issues Early diagnosis and consistent medical oversight are crucial in managing this condition and reducing the risk of kidney failure.
Clinical Advice & FAQs
Billing Guidance
Is N05.A a billable ICD-10 code?
Yes, N05.A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N05.A?
Clinical documentation must specify the nature of Unspecified nephritic syndrome with C3 glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference